Home > SWOT Analysis > Cytori Therapeutics (CYTX) SWOT Analysis






Cytori Therapeutics (CYTX) SWOT Analysis Profile

Cytori Therapeutics, Inc., founded in 1996, develops and manufactures products specific to regenerative medicine and the treatment of cardiovascular disease, orthopedic damage, gastrointestinal disorders, and pelvic health. Products include the Celution System which processes patients' cells at the bedside in real time and products for reconstructive surgery. It is also a partner in the StemSource Cell Bank which prepares cells for cryopreservation, and operates a tissue bank facility for the preservation of stem and regenerative cells. Cytori Therapeutics is headquartered in San Diego, California. (read full profile)

Additional Information

What is a SWOT Analysis? It is a way of evaluating the strengths, weaknesses, opportunities, and threats that affect something. See WikiWealth's SWOT tutorial for help. Remember, vote up the most important comments. Check out WikiWealth's entire database of free SWOT reports or use our SWOT analysis generator to create your own SWOT template.

Receive News & Ratings Via Email